Coagulation factor XII
Sign in to saveAlso known as Hageman factor, beta-factor XIIa part 1, HAF, beta-factor XIIa part 2, F12, coagulation factor XIIa light chain, coagulation factor XIIa heavy chain
mammalian protein found in Homo sapiens
Protein · UniProt
Coagulation factor XII
- Gene
- F12
- Organism
- Homo sapiens (Human)
- Length
- 615 aa
- Molecular mass
- 67,792 Da
- Evidence
- 1: Evidence at protein level
Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa (PubMed:2019570, PubMed:21304106, PubMed:8427954)
3D-structureBlood coagulationDirect protein sequencingDisease variantDisulfide bondEGF-like domainFibrinolysisGlycoprotein
View on UniProt →
Swiss-Prot (reviewed) · via UniProt
Research
5,180 papers- Coagulation factor XII in thrombosis and inflammation.Blood · 2018
- Factor XII in coagulation, inflammation and beyond.Cellular signalling · 2018
- Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis.Nature communications · 2025
- The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.Frontiers in immunology · 2018
- Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease.Nature communications · 2024
via PubMed
Clinical Trials
8 registered- NAUNKNOWNThe Proteins of the Contact Activation SystemHospices Civils de Lyon · NCT02785718
- UNKNOWNThrombus Formation Under Different Flow-conditionsMaastricht University Medical Center · NCT01114074
- COMPLETEDThe Contact Activation System and Ulcerative ColitisEsbjerg Hospital - University Hospital of Southern Denmark · NCT04621006
- PHASE1COMPLETEDPhase 1 Safety and Tolerability Study of REGN9533 in Healthy AdultsRegeneron Pharmaceuticals · NCT06665828
- PHASE1ACTIVE_NOT_RECRUITINGPhase 1 Safety and Tolerability Study of ALN-F1202 in Healthy AdultsRegeneron Pharmaceuticals · NCT06669234
- COMPLETEDRisk Markers in the Acute Coronary SyndromesHelse Stavanger HF · NCT00521976